pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
Jun 17, 26
STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval
stat
Jun 16, 26
FDA raises no major red flags with Moderna's flu shot
endpoints
Jun 16, 26
FDA greenlights Colorado's drug import proposal
endpoints
Jun 16, 26
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
biopharma dive
Jun 16, 26
Edgewise to advance heart drug into Phase 3 following mid-stage data update
endpoints
Jun 16, 26
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
stat
Jun 16, 26
Neumora depression drug fails; EnGene to cut 50% of staff
biopharma dive
Jun 16, 26
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
fda press
Jun 15, 26
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
fda press
Jun 15, 26
CMS seeks to close Medicare negotiation 'loophole'
endpoints
Jun 15, 26
STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
stat
Jun 15, 26
STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
stat
Jun 15, 26
J&J multiple myeloma drug gains edge in earlier stage disease
biopharma dive
Jun 15, 26
STAT+: Lilly’s Ajax acquisition may have been worth it
stat
Jun 13, 26
STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
stat
Jun 12, 26
Merck brings Welireg-Keytruda combo to treat kidney cancer
endpoints
Jun 12, 26
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
biopharma dive
Jun 11, 26
Summit pulls $500M share sale a day after announcing it
biopharma dive
Jun 11, 26
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
biopharma dive
Jun 11, 26
Camurus’ second CRL for acromegaly drug; Teva details workforce cuts
endpoints
Jun 11, 26
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
biopharma dive
Jun 11, 26
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
biopharma dive
Jun 10, 26
DOJ reaches second settlement on youth gender care
stat
Jun 10, 26
Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care
stat
Jun 9, 26
FDA OKs first new sunscreen ingredient in more than 25 years
stat
Jun 9, 26
Grace Science says FDA bottleneck jeopardizes rare disease therapy
endpoints
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
FDA Expands Sunscreen Options for the First Time in 20 Years
fda press
Jun 9, 26
GSK boosts cancer pipeline with $11B Nuvalent buyout
biopharma dive
← prev
page 44 of 52
next →